NTLA Stockholders Have Opportunity to Lead Intellia Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. (NASDAQ:NTLA) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for investors who acquired Intellia securities between July 30, 2024, and January 8, 2025.
March 05, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged violations of federal securities laws, potentially impacting its stock price.
The lawsuit against Intellia Therapeutics for alleged securities law violations could lead to negative sentiment among investors, potentially causing a short-term decline in NTLA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100